Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.
At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.
As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.
To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.
ESSENTIAL JOB FUNCTIONS:
The Dir/Sr Director, Commercial Legal and Compliance role involves providing legal and compliance support to Kura Oncology's late-stage pipeline programs, including in preparation for, and in implementation of, potential product launches. The role requires collaboration with various teams to ensure compliance with regulations and support commercialization activities. The successful candidate will partner creatively and fully with business teams to achieve critical objectives while mitigating the potential impact of compliance risks. This role will support the Chief Compliance Officer with the development and implementation of the company’s compliance program, related policies and trainings.
- Provide legal and compliance support for Kura Oncology’s late-stage pipeline programs approaching potential commercialization and potential future commercial products.
- Provide legal advice and counseling on healthcare, commercial and general corporate topics.
- Support preparations for and implementation of potential future commercial product launches, including pre-approval activities and marketing strategies.
- Serve as the primary legal support for the Commercial, Sales, Marketing, Market Access and Medical teams with respect to late-stage pipeline programs and potential future commercial products.
- Advise business on advertising and promotion of pharmaceutical products, including compliance with FDA regulations, fraud and abuse requirements, interactions with healthcare providers and patients, market access arrangements and Sunshine Act compliance.
- Serve as Legal representative on Medical, Legal, Regulatory Review Committee (MLR).
- Review and approve scientific, disease state, and promotional campaigns, including communications with healthcare providers, patients and payors.
- Advise on reimbursement activities, access services and patient support programs.
- Support Sunshine Act compliance and reporting.
- Support the Chief Compliance Officer to develop and implement policies, resources and training to drive comprehensive, functional knowledge among product teams on business conduct in accordance with legal and ethical standards.
- Support the Chief Compliance Officer to implement Kura Oncology's healthcare compliance program and Code of Business Conduct and Ethics.
- Serve as non-voting member of the appropriate committees with US commercialization partner Kyowa Kirin, ensuring alignment across teams while driving resolution of commercial legal challenges as required.
- Support the drafting and negotiation of third-party contracts, including agreements with healthcare providers, academic institutions, vendors and distributors.
- Manage external counsel as necessary.
JOB SPECIFICATIONS:
- 12+ years of relevant attorney experience, including in-house experience at leading biotech or pharmaceutical companies.
- Prior drug launch experience for oncology therapies.
- Admitted and in good standing with a state bar and eligible to register as in-house counsel in California.
- Demonstrated excellent communication, teamwork, and problem-solving skills.
- Ability to manage multiple client demands and shifting priorities in a fast-paced environment.
- Juris Doctor degree and strong academic credentials.
The base range for this role at the Director level is $239,720 - $269,704 and Senior Director level is $294,790 - $328,885 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
#LI-RM1
Kura’s Values that are used for candidate selection and performance assessments:
- We work as one for patients
- We are goal-focused and deliver with excellence
- We are science-driven courageous innovators
- We strive to bring out the best in each other and ourselves
The Kura Package
- Career advancement/ development opportunities
- Competitive comp package
- Bonus
- 401K + Employer contributions
- Generous stock options
- ESPP Plan
- 20 days of PTO to start
- 18 Holidays (Including Summer & Winter Break)
- Generous Benefits Package with a variety of plans available with a substantial employer match
- Paid Paternity/Maternity Leave
- In-Office Catered lunches
- Home Office Setup
- Lifestyle Spending Stipend
- Commuter Stipend (Boston Office)
- Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.
Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.
Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
Similar Jobs
.jpeg)
What you need to know about the Los Angeles Tech Scene
Key Facts About Los Angeles Tech
- Number of Tech Workers: 375,800; 5.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Snap, Netflix, SpaceX, Disney, Google
- Key Industries: Artificial intelligence, adtech, media, software, game development
- Funding Landscape: $11.6 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Strong Ventures, Fifth Wall, Upfront Ventures, Mucker Capital, Kittyhawk Ventures
- Research Centers and Universities: California Institute of Technology, UCLA, University of Southern California, UC Irvine, Pepperdine, California Institute for Immunology and Immunotherapy, Center for Quantum Science and Engineering
